J&J Faces Possible Criminal Liability As Post-Recall Overhaul Continues
This article was originally published in The Tan Sheet
Executive Summary
FDA's drug center referred its review of Johnson & Johnson's manufacturing operations to the Office of Criminal Investigations, which will determine whether there is criminal liability in the quality control lapses that led to extensive recalls of OTC drugs
You may also be interested in...
J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.
J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.
J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.